These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11115437)

  • 21. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
    Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
    J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
    D'Urzo A
    Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
    Brannan MD; Herron JM; Reidenberg P; Affrime MB
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M; Jarvis B
    Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.
    Karpel J; D'urzo A; Lockey RF
    J Asthma; 2008 Nov; 45(9):747-53. PubMed ID: 18972289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
    Holgate ST; Arshad H; Stryszak P; Harrison JE
    J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.
    Calverley PM; Rennard S; Nelson HS; Karpel JP; Abbate EH; Stryszak P; Staudinger H
    Respir Res; 2008 Nov; 9(1):73. PubMed ID: 19014549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH; Krouse HJ; Janisse JJ
    Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
    Maspero JF; Nolte H; Chérrez-Ojeda I;
    J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
    Price D; Robertson A; Bullen K; Rand C; Horne R; Staudinger H
    BMC Pulm Med; 2010 Jan; 10():1. PubMed ID: 20051135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
    Zetterström O; Dahl R; Lindqvist A; Olsson P
    Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.
    Zeidler M; Corren J; Tashkin DP
    Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
    Kemp JP; Berkowitz RB; Miller SD; Murray JJ; Nolop K; Harrison JE
    J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.